ArticleFrontiers in oncology2023

MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.

Hazel Lote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.